Graduate students are young and don’t often feel the effects of repetitive motion injuries. But that’s not the case in industry and manufacturing, where the glovebox workforce is aging and workers report severe symptoms.
No pandemic can stop an underwriter from getting the job done. We celebrate many in the insurance industry this year as we continue to push through such a difficult time, all while aiming for success.
Oaths provide a sense of duty and accountability to the ones who take them. They instill a true mission into professionals. They provide a clear path to return to, should one fall short.
Great leadership demands diligence, foresight and courage, no matter the economic cycle. Risk & Insurance and four industry leaders discuss the traits and skills business and risk management leaders should bring to the table to help organizations succeed.
Cyber security risk has become a prominent threat for companies and businesses alike. Many fear that a cyber attack could result in loss of information or data. But a recent cyber security breach at a water treatment facility in Florida has made it clear that no entity is safe.
Though plaintiffs will have a tough time blaming businesses for exposure to the virus, carriers are nonetheless prepping defense strategies and emphasizing risk mitigation to clients.
Telemedicine use surged as the pandemic forced more employees to work from home. Though in-person doctor visits have resumed, it’s likely that telemedicine will remain a prominent part of medical treatment. Its increased use presents a challenging slew of risks.
After a damaging winter storm in 2011, officials in Texas received recommendations on weatherizing the state’s grid. Those recommendations were not followed, and in 2021, Texans paid a big price.
As supply chains continue to lean into a digitized marketplace, it is imperative that risk managers view every potential threat that could manifest into a true cyber catastrophe.
When Purdue Pharma was first sussed out as a leading cause of the opioid epidemic in the U.S., it wouldn’t be long until the pharmaceutical company’s partners were feeling the heat.